1. Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex
- Author
-
Benjamin F. Cravatt, David G. Stouffer, Marisa Roberto, Ilham Polis, Rémi Martin-Fardon, Loren H. Parsons, Antonia Serrano, Francisco Javier Pavón, Fernando Rodríguez de Fonseca, [Pavón,FJ, Polis,IY, Stouffer,DG, Roberto,M, Martin-Fardon,R, Parsons,LH, Serrano,A] Department of Neuroscience, The Scripps Research Institute, La Jolla, CA, USA. [Pavón,FJ, Rodríguez de Fonseca,F, Serrano,A] Unidad de Gestión Clínica de Salud Mental, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. [Pavón,FJ] CIBERCV-Instituto de Salud Carlos III and Unidad de Gestión Clínica del Corazón, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. [Cravatt,BF] Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA., This work was supported by the following funding sources and grants: the National Institute on Alcohol Abuse and Alcoholism (AA020404, AA022249, AA024146 and AA026999 to RMF, AA006420 to RMF and MR, AA017447 and AA015566 to MR), Pearson Center for Alcoholism and Addiction Research, Instituto de Salud Carlos III (ISCIII) and European Regional Development Funds-European Union (ERDF-EU) [Subprograma RETICS Red de Trastornos Adictivos (RD16/0017/0001), Ministerio de Economía y Competitividad (PI16/01953, PI16/01698, PI17/02026, PI19/01577 and PI19/00886)], Ministerio de Sanidad and Delegacion ´ del Gobierno para el Plan Nacional sobre Drogas (PND2017/ 043, PND2018/044 and PND2018/033), and and Junta de Andalucía and ERDF-EU [Consejería de Economía, Innovacion ´ y Ciencia (CTS-433 and CTS-1052) and Servicio Andaluz de Salud (C1-0049-2019)]. AS and FJP hold a 'Miguel Servet' research contract funded by ISCIII and ERDF-EU (CPII19/00031 and CPII19/00022, respectively). This is article number 29846 from The Scripps Research Institute.
- Subjects
Mouse ,Physiology ,Ratones ,Dopamine ,Microdialysis ,2-Arachidonoylglycerol ,Dopamina ,Biochemistry ,chemistry.chemical_compound ,0302 clinical medicine ,Endocrinology ,Fatty acid amide hydrolase ,Chemicals and Drugs::Biological Factors::Inflammation Mediators::Autacoids::Serotonin [Medical Subject Headings] ,Original Research Article ,JZL184 ,QP351-495 ,Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Signal Transduction [Medical Subject Headings] ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Adaptation, Psychological [Medical Subject Headings] ,Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Esterases::Carboxylic Ester Hydrolases::Monoacylglycerol Lipases [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Immobilization::Restraint, Physical::Hindlimb Suspension [Medical Subject Headings] ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Central Nervous System Agents::Central Nervous System Depressants::Tranquilizing Agents::Anti-Anxiety Agents [Medical Subject Headings] ,lipids (amino acids, peptides, and proteins) ,Anatomy::Nervous System::Central Nervous System::Brain::Prosencephalon::Telencephalon::Cerebrum::Cerebral Cortex::Frontal Lobe::Prefrontal Cortex [Medical Subject Headings] ,psychological phenomena and processes ,RC321-571 ,Neurophysiology and neuropsychology ,medicine.medical_specialty ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Stress-coping behavior ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Internal medicine ,medicine ,Chemicals and Drugs::Lipids::Fatty Acids::Endocannabinoids [Medical Subject Headings] ,RC346-429 ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Emotions::Anxiety [Medical Subject Headings] ,Molecular Biology ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice [Medical Subject Headings] ,Endocrine and Autonomic Systems ,Tail suspension test ,030227 psychiatry ,Monoacylglycerol lipase ,Microdiálisis ,chemistry ,Neurology. Diseases of the nervous system ,030217 neurology & neurosurgery ,JZL195 ,Behavioural despair test - Abstract
The endocannabinoid system is involved in the regulation of the stress response, but the relative contribution of N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) and their mechanisms have to be elucidated. In this study, we compared the effects of the pharmacological inhibition of the two major endocannabinoid-degrading enzymes [fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) for AEA and 2-AG, respectively] on stress-coping [forced swim test (FST) and tail suspension test (TST)] and anxiety-like [elevated-plus maze (EPM) and light-dark test (LDT)] behaviors in wild-type and FAAH knockout mice. In vivo microdialysis estimated the effects of FAAH and MAGL inhibition on dopamine (DA) and serotonin (5-HT) levels in the medial prefrontal cortex (mPFC) during an FST. Mice were treated with PF-3845 (FAAH inhibitor), JZL184 (MAGL inhibitor), JZL195 (dual FAAH/MAGL inhibitor) or vehicle. Our data showed that PF-3845 increased latency to immobility and decreased total immobility time in FST, but no effects were observed in TST compared with vehicle-treated wild-type mice. By contrast, JZL184 decreased latency and increased immobility in TST and FST. JZL195 in wild-type mice and JZL184 in FAAH knockout mice reproduced the same passive coping behaviors as JZL184 in wild-type mice in TST and FST. In the microdialysis experiment, FST was associated with increased DA and 5-HT levels in the mPFC. However, JZL184-treated wild-type mice displayed a significant attenuation of forced swim stress-induced DA release compared with vehicle-treated wild-type mice and PF-3845-treated wild-type mice. Finally, FAAH and/or MAGL inhibitors induced robust and consistent anxiolytic-like effects in EPM and LDT. These results suggested differences between FAAH and MAGL inhibition in stress-coping behaviors. Notably, MAGL inhibition induced a consistent avoidant coping behavior and attenuated the stress-induced mPFC DA response in FST. However, more investigation is needed to elucidate the functional association between DA and 2-AG signaling pathways, and the molecular mechanism in the regulation of passive coping strategies during inescapable stress., Highlights • FAAH and/or MAGL inhibition induce opposite changes in stress-coping behaviors. • MAGL inhibition increases passive stress-coping behaviors in mice. • Passive stress-coping behaviors are regulated by 2-AG rather than AEA signaling. • MAGL inhibition attenuates mPFC dopamine increase in the forced swim test. • FAAH and/or MAGL inhibitors are associated with anxiolytic-like effects.
- Published
- 2021